TY - JOUR
T1 - Neurocognitive function in pediatric bipolar disorder
T2 - 3-year follow-up shows cognitive development lagging behind healthy youths
AU - Pavuluri, Mani N.
AU - West, Amy
AU - Hill, S. Kristian
AU - Jindal, Kittu
AU - Sweeney, John A.
N1 - Funding Information:
This study was supported by NIH/NCRR K23 and RR018638–01.
PY - 2009/3
Y1 - 2009/3
N2 - Objective: Longitudinal follow-up of neurocognltive functioning in people with pediatric bipolar disorder (PBD) was conducted to characterize the developmental trajectory of cognitive disabilities in this disorder. Method: Patients with PBD (n = 26) and controls (HC; n = 17; mean age 11.66 ± 2.70 years) completed cognitive testing at baseline and then again at a 3-year follow-up. Groups were matched at baseline on age, sex, race, parental socioeconomic status, general intelligence, and single-word reading ability. The PBD group received treatment guided by a standardized medication algorithm during the 3-year period. A battery of neuropsychological tests was administered to assess attention, executive function, working memory, verbal memory, visual memory, and visuospatial perception at baseline and follow-up. Results: At baseline and follow-up, the patients showed deficits in all of the examined domains. At 3-year follow-up, developmental progress in executive functions and verbal memory was significantly less in the patients with PBD than in the HC. Improvement on attention, working memory, visual memory, and visuospatial perception tasks in the patients with PBD was comparable to that of the HC, but the patients with PBD remained impaired in all domains relative to the HC. Conclusions: The developmental delay in some neurocognitive functioning in PBD suggests that the illness disrupts cognitive development with potential lifelong implications for reduced functional ability. Treating bipolar symptoms does not seem to prevent the lag in cognitive development. This dysmaturation may be a direct effect of the illness on brain function, or it may represent indirect consequences of psychopathology or medications on cognitive development.
AB - Objective: Longitudinal follow-up of neurocognltive functioning in people with pediatric bipolar disorder (PBD) was conducted to characterize the developmental trajectory of cognitive disabilities in this disorder. Method: Patients with PBD (n = 26) and controls (HC; n = 17; mean age 11.66 ± 2.70 years) completed cognitive testing at baseline and then again at a 3-year follow-up. Groups were matched at baseline on age, sex, race, parental socioeconomic status, general intelligence, and single-word reading ability. The PBD group received treatment guided by a standardized medication algorithm during the 3-year period. A battery of neuropsychological tests was administered to assess attention, executive function, working memory, verbal memory, visual memory, and visuospatial perception at baseline and follow-up. Results: At baseline and follow-up, the patients showed deficits in all of the examined domains. At 3-year follow-up, developmental progress in executive functions and verbal memory was significantly less in the patients with PBD than in the HC. Improvement on attention, working memory, visual memory, and visuospatial perception tasks in the patients with PBD was comparable to that of the HC, but the patients with PBD remained impaired in all domains relative to the HC. Conclusions: The developmental delay in some neurocognitive functioning in PBD suggests that the illness disrupts cognitive development with potential lifelong implications for reduced functional ability. Treating bipolar symptoms does not seem to prevent the lag in cognitive development. This dysmaturation may be a direct effect of the illness on brain function, or it may represent indirect consequences of psychopathology or medications on cognitive development.
KW - Bipolar
KW - Cognition
KW - Development
KW - Neurocognitive
UR - http://www.scopus.com/inward/record.url?scp=62849120975&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=62849120975&partnerID=8YFLogxK
U2 - 10.1097/CHI.0b013e318196b907
DO - 10.1097/CHI.0b013e318196b907
M3 - Article
C2 - 19182689
AN - SCOPUS:62849120975
SN - 0890-8567
VL - 48
SP - 299
EP - 307
JO - Journal of the American Academy of Child Psychiatry
JF - Journal of the American Academy of Child Psychiatry
IS - 3
ER -